Arrowhead Pharmaceuticals Inc (ARWR)
24.77
-0.23
(-0.92%)
USD |
NASDAQ |
May 17, 16:00
24.77
0.00 (0.00%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Free Cash Flow: -470.16M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -470.16M |
December 31, 2023 | -402.70M |
September 30, 2023 | -330.63M |
June 30, 2023 | -342.91M |
March 31, 2023 | -353.21M |
December 31, 2022 | -236.25M |
September 30, 2022 | -188.91M |
June 30, 2022 | -119.69M |
March 31, 2022 | -74.88M |
December 31, 2021 | 123.85M |
September 30, 2021 | 147.74M |
June 30, 2021 | 166.83M |
March 31, 2021 | 164.80M |
December 31, 2020 | -123.10M |
September 30, 2020 | -107.75M |
June 30, 2020 | -88.63M |
March 31, 2020 | -45.76M |
December 31, 2019 | -34.36M |
September 30, 2019 | 161.03M |
June 30, 2019 | 151.66M |
March 31, 2019 | 129.75M |
December 31, 2018 | 133.73M |
September 30, 2018 | -48.64M |
June 30, 2018 | -54.57M |
March 31, 2018 | -51.53M |
Date | Value |
---|---|
December 31, 2017 | -51.39M |
September 30, 2017 | -31.86M |
June 30, 2017 | -35.44M |
March 31, 2017 | -42.87M |
December 31, 2016 | -42.03M |
September 30, 2016 | -68.29M |
June 30, 2016 | -68.25M |
March 31, 2016 | -62.65M |
December 31, 2015 | -64.48M |
September 30, 2015 | -67.68M |
June 30, 2015 | -66.21M |
March 31, 2015 | -63.23M |
December 31, 2014 | -54.75M |
September 30, 2014 | -37.13M |
June 30, 2014 | -31.25M |
March 31, 2014 | -26.32M |
December 31, 2013 | -22.62M |
September 30, 2013 | -19.33M |
June 30, 2013 | -18.51M |
March 31, 2013 | -17.02M |
December 31, 2012 | -16.89M |
September 30, 2012 | -15.82M |
June 30, 2012 | -12.81M |
March 31, 2012 | -9.832M |
December 31, 2011 | -6.752M |
Free Cash Flow Range, Past 5 Years
-470.16M
Minimum
Mar 2024
166.83M
Maximum
Jun 2021
-100.15M
Average
-98.19M
Median
Free Cash Flow Benchmarks
89bio Inc | -138.82M |
Madrigal Pharmaceuticals Inc | -391.12M |
Viking Therapeutics Inc | -54.87M |
Akero Therapeutics Inc | -155.88M |
Sagimet Biosciences Inc | -22.89M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -92.38M |
Cash from Investing (Quarterly) | -268.94M |
Cash from Financing (Quarterly) | 430.78M |
Free Cash Flow Per Share (Quarterly) | -1.026 |
Free Cash Flow Yield | -17.06% |